e-Lung Biomarkers Are Associated with Future Progressive Pulmonary Fibrosis Independent of UIP Status on CT

George PM et al

ATS 2025

May 21, 2025

Rationale

  • A UIP pattern on CT has been considered the strongest prognostic indicator in interstitial lung disease
  • Data emerging that UIP may be less prognostic than disease extent
  • e-Lung is an AI powered CT tool which accurately quantifies the extent of fibrosis on CT
  • The weighted reticulovascular score (WRVS) quantifies fibrosis in the peripheral lung 
  • We evaluated the prognostic potential for WRVS compared with UIP and visual extent of disease in patients with non-IPF fibrotic ILD

 

Methods & Demographics

  • 302 consecutive patients with non-IPF fibrotic ILD
  • UIP status assessed by expert thoracic ILD radiologist (AD)
    • Definite and Probable UIP = UIP
    • Indeterminate and alternative diagnosis = non-UIP
  • Visual disease extent scored by two experienced thoracic radiologists
  • Evaluated relationships between WRVS, visual disease extent, UIP pattern on CT and outcomes
  • Mean visual extent of fibrosis 21.6%
  • Mean FVC 83%, Mean age 65, f=114 (44%)

 

Results

  • WRVS more strongly associated with mortality and FVC decline than visual extent of disease or UIP

 

Conclusions

  • In patients with non-IPF ILD, the e-Lung WRVS CT biomarker is associated with mortality independent of UIP status
  • While both UIP and WRVS are associated with mortality, WRVS is a stronger prognostic factor 
  • WRVS and not UIP is associated with future FVC decline regardless of imaging subtype
  • In early disease where extent of disease is challenging to quantify visually, UIP status may be more important – e-Lung adds prognostic accuracy

Collaborating and Innovating with our Partners